Cost‐effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China

BACKGROUND AND OBJECTIVE: To evaluate the cost-effectiveness of new anticoagulants and warfarin in the prevention of stroke in Chinese patients with atrial fibrillation (AF). METHODS: The Markov model was constructed to compare patients’ quality-adjusted life-years (QALYs) using drug cost, the cost...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Health Serv Res
Hlavní autoři: Wei, Hongtao, Cui, Can, Cui, Xiangli, Liu, Yi, Li, Dandan
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7841891/
https://ncbi.nlm.nih.gov/pubmed/33509171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-021-06084-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky